These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31542859)

  • 1. Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice.
    Sha S; Liu X; Zhao R; Qing L; He Q; Sun L; Chen L
    Endocrine; 2019 Dec; 66(3):494-502. PubMed ID: 31542859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
    Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
    Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
    Elvert R; Herling AW; Bossart M; Weiss T; Zhang B; Wenski P; Wandschneider J; Kleutsch S; Butty U; Kannt A; Wagner M; Haack T; Evers A; Dudda A; Lorenz M; Keil S; Larsen PJ
    Diabetes Obes Metab; 2018 Aug; 20(8):1836-1851. PubMed ID: 29938884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice.
    Heppner KM; Marks S; Holland J; Ottaway N; Smiley D; Dimarchi R; Perez-Tilve D
    Diabetologia; 2015 Sep; 58(9):2124-32. PubMed ID: 26049402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
    Le TDV; Fathi P; Watters AB; Ellis BJ; Besing GK; Bozadjieva-Kramer N; Perez MB; Sullivan AI; Rose JP; Baggio LL; Koehler J; Brown JL; Bales MB; Nwaba KG; Campbell JE; Drucker DJ; Potthoff MJ; Seeley RJ; Ayala JE
    Mol Metab; 2023 Jun; 72():101718. PubMed ID: 37030441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.
    Adams JM; Pei H; Sandoval DA; Seeley RJ; Chang RB; Liberles SD; Olson DP
    Diabetes; 2018 Aug; 67(8):1538-1548. PubMed ID: 29776968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Beneficial Metabolic Effects of Liraglutide and Semaglutide in Male C57BL/6J Mice.
    Liu D; Gu J; Shao W; Pang J; Qian X; Jin T
    Can J Diabetes; 2022 Apr; 46(3):216-224.e2. PubMed ID: 35568421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity.
    Liu J; Aylor KW; Liu Z
    Diabetes; 2023 Jul; 72(7):918-931. PubMed ID: 37074396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet.
    Baldassano S; Amato A; Caldara GF; Mulè F
    Endocrine; 2016 Dec; 54(3):648-656. PubMed ID: 26832341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein.
    Zhou W; Shao W; Zhang Y; Liu D; Liu M; Jin T
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E568-E578. PubMed ID: 32723174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 receptor agonist, liraglutide, ameliorates hepatosteatosis induced by anti-CD3 antibody in female mice.
    Itoh A; Irie J; Tagawa H; Kusumoto Y; Kato M; Kobayashi N; Tanaka K; Kikuchi R; Fujita M; Nakajima Y; Wu Y; Yamada S; Kawai T; Ridgway WM; Itoh H
    J Diabetes Complications; 2017 Sep; 31(9):1370-1375. PubMed ID: 28684145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High fat diet and GLP-1 drugs induce pancreatic injury in mice.
    Rouse R; Xu L; Stewart S; Zhang J
    Toxicol Appl Pharmacol; 2014 Apr; 276(2):104-14. PubMed ID: 24534256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
    Frøssing S; Nylander M; Chabanova E; Frystyk J; Holst JJ; Kistorp C; Skouby SO; Faber J
    Diabetes Obes Metab; 2018 Jan; 20(1):215-218. PubMed ID: 28681988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
    Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
    Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
    Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators.
    Decara J; Arrabal S; Beiroa D; Rivera P; Vargas A; Serrano A; Pavón FJ; Ballesteros J; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
    Biofactors; 2016 Nov; 42(6):600-611. PubMed ID: 27213962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats.
    Krieger JP; Langhans W; Lee SJ
    Physiol Behav; 2018 Aug; 192():194-199. PubMed ID: 29654813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide reduces body weight by upregulation of adenylate cyclase 3.
    Li Z; Liang Y; Xia N; Lai Y; Pan H; Zhou S; Jiang F; He Y
    Nutr Diabetes; 2017 May; 7(5):e265. PubMed ID: 28481334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.
    Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.